Keith Flaherty
Director
Nanoscience and Nanotechnology
 Viralytics
Australia
Biography
Dr. Flaherty is Chair of the Clinical Advisory Board and previously served on Viralytics’ Scientific Advisory Board. He is Director of the Henri and Belinda Termeer Center for Targeted Therapies at the Massachusetts General Hospital Cancer Center and he is an Professor of Medicine at Harvard Medical School. His research and clinical focus is on melanoma with a particular expertise in targeted therapies. Dr. Flaherty has been the Principal Investigator for numerous human clinical trials with a focus on novel, targeted drugs for metastatic melanoma patients. In these trials, he focused on the development of response and predictive biomarkers to define the mechanisms of action and resistance of novel therapies, as well as to identify the optimal target population.
Research Interest
Nanoscience and Nanotechnology
